- Home
- JAKK vs TLSI Comparison
JAKK vs TLSI Comparison
Compare JAKK & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- TLSI
- Stock Information
- Founded
- JAKK 1995
- TLSI 2010
- Country
- JAKK United States
- TLSI United States
- Employees
- JAKK N/A
- TLSI N/A
- Industry
- JAKK Recreational Games/Products/Toys
- TLSI Medical Specialities
- Sector
- JAKK Consumer Discretionary
- TLSI Health Care
- Exchange
- JAKK Nasdaq
- TLSI Nasdaq
- Market Cap
- JAKK 230.6M
- TLSI 204.0M
- IPO Year
- JAKK 1996
- TLSI N/A
- Fundamental
- Price
- JAKK $20.80
- TLSI $4.93
- Analyst Decision
- JAKK Strong Buy
- TLSI Strong Buy
- Analyst Count
- JAKK 4
- TLSI 5
- Target Price
- JAKK $41.75
- TLSI $10.90
- AVG Volume (30 Days)
- JAKK 124.6K
- TLSI 154.5K
- Earning Date
- JAKK 07-30-2025
- TLSI 08-13-2025
- Dividend Yield
- JAKK 4.83%
- TLSI N/A
- EPS Growth
- JAKK 47.04
- TLSI N/A
- EPS
- JAKK 4.03
- TLSI N/A
- Revenue
- JAKK $714,219,000.00
- TLSI $32,141,000.00
- Revenue This Year
- JAKK N/A
- TLSI $55.52
- Revenue Next Year
- JAKK $3.90
- TLSI $54.76
- P/E Ratio
- JAKK $5.13
- TLSI N/A
- Revenue Growth
- JAKK 2.89
- TLSI 46.20
- 52 Week Low
- JAKK $17.20
- TLSI $3.50
- 52 Week High
- JAKK $35.79
- TLSI $6.04
- Technical
- Relative Strength Index (RSI)
- JAKK 50.34
- TLSI 45.84
- Support Level
- JAKK $20.10
- TLSI $4.78
- Resistance Level
- JAKK $21.15
- TLSI $5.20
- Average True Range (ATR)
- JAKK 0.71
- TLSI 0.31
- MACD
- JAKK -0.03
- TLSI -0.03
- Stochastic Oscillator
- JAKK 63.13
- TLSI 30.29
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.